بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی
به گزارش روابط عمومی گروه دارویی برکت دکتر اکبر برندگی مدیر عامل شرکت گروه دارویی برکت به همراه مدیران این...
به گزارش روابط عمومی گروه دارویی برکت دکتر اکبر برندگی مدیر عامل شرکت گروه دارویی برکت به همراه مدیران این...
The writing of this article, which reports the clinical trial findings of phase one and two of the BIV1-CovIran vaccine,...
With the widespread spread of the Amicron Corona virus strain, the specialists of the Barakat Pharmaceutical Group produced a special...
The study of the effectiveness of Covid 19 vaccines including Barakat, Strazenka, Sinofarm and Sputnik after the study in Isfahan...
The first article in the clinical study of Bovine Bovine, entitled Evaluation of the Neutralizing Properties of the Bovine Vaccine...
According to the report of the stock exchange of the economic group of the Young Journalists Club, based on the...
The increase of 1,807 billion Tomans in the value of Alborz Holding had the greatest impact on this growth.
Shares of Barakat Pharmaceutical Group in today's stock exchange, after trading at 150 billion, with a decline of 4.4 percent,...
The article on the clinical and technical knowledge of Bovine Bovine Vaccine was published in one of the most prestigious...
Previous experiments have shown the high efficacy of the Bovine Bovine vaccine against the English variant.
Barkat Pharmaceutical Group is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company’s name was was changed to “Tadbir innovation pharmaceutical company” in 2010.
Address : No. 11, 5th Alley, Bucharest Ave, Argentina Sq, Tehran, Iran
Phone : +98 21 88480161
Email : info@bpharmed.com
Email Affairs Stock : stock@bpharmed.com